SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-004517
Accepted
2021-12-02 00:15:12
Documents
1
Effectiveness Date
2021-12-01
Registration Form
POS AM
Reference AccNo
0001493152-21-030102

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 610
  Complete submission text file 9999999995-21-004517.txt   1825
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-230016 | Film No.: 211464859
SIC: 2834 Pharmaceutical Preparations